Actuate Therapeutics Inc Statistics Share Statistics Actuate Therapeutics Inc has 20.74M
shares outstanding. The number of shares has increased by 0.45%
in one year.
Shares Outstanding 20.74M Shares Change (YoY) 0.45% Shares Change (QoQ) 0.45% Owned by Institutions (%) 53.35% Shares Floating 7.07M Failed to Deliver (FTD) Shares 31 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 549.34K, so 2.65% of the outstanding
shares have been sold short.
Short Interest 549.34K Short % of Shares Out 2.65% Short % of Float 7.59% Short Ratio (days to cover) 14.83
Valuation Ratios The PE ratio is -2.44 and the forward
PE ratio is -5.38.
Actuate Therapeutics Inc's PEG ratio is
-0.03.
PE Ratio -2.44 Forward PE -5.38 PS Ratio 0 Forward PS n/a PB Ratio 639.69 P/FCF Ratio -3.05 PEG Ratio -0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Actuate Therapeutics Inc.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.05,
with a Debt / Equity ratio of 3.89.
Current Ratio 1.05 Quick Ratio 1.05 Debt / Equity 3.89 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 1344.27
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.73M Employee Count 10 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 800 Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 21.03% in the
last 52 weeks. The beta is 0.15, so Actuate Therapeutics Inc's
price volatility has been higher than the market average.
Beta 0.15 52-Week Price Change 21.03% 50-Day Moving Average 7.48 200-Day Moving Average 8.02 Relative Strength Index (RSI) 44.64 Average Volume (20 Days) 106,422
Income Statement
Revenue n/a Gross Profit n/a Operating Income -25.16M Net Income -27.29M EBITDA -25.16M EBIT -27.3M Earnings Per Share (EPS) -3.26
Full Income Statement Balance Sheet The company has 8.64M in cash and 404.99K in
debt, giving a net cash position of 8.24M.
Cash & Cash Equivalents 8.64M Total Debt 404.99K Net Cash 8.24M Retained Earnings -132.38M Total Assets 6.97M Working Capital -2.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -21.84M
and capital expenditures 0, giving a free cash flow of -21.84M.
Operating Cash Flow -21.84M Capital Expenditures n/a Free Cash Flow -21.84M FCF Per Share -2.61
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
